Rankings
▼
Calendar
BMY Q3 2016 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena
BMY
Bristol-Myers Squibb Company
$120B
Q3 2016 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$4.9B
Gross Profit
$3.6B
73.5% margin
Operating Income
$1.3B
27.1% margin
Net Income
$1.2B
24.4% margin
EPS (Diluted)
$0.72
QoQ Revenue Growth
+1.0%
Cash Flow
Operating Cash Flow
$1.4B
Free Cash Flow
$1.1B
Stock-Based Comp.
$48M
Balance Sheet
Total Assets
$33.7B
Total Liabilities
$17.9B
Stockholders' Equity
$15.6B
Cash & Equivalents
$3.4B
Revenue Segments
Opdivo
$920M
19%
Eliquis
$884M
18%
Orencia
$572M
12%
Mature Products And All Other
$521M
11%
Sprycel
$472M
10%
Hepatitis C Portfolio
$379M
8%
Baraclude
$306M
6%
Yervoy
$285M
6%
Sustiva Franchise
$275M
6%
Reyataz
$238M
5%
Empliciti
$41M
1%
Abilify
$29M
1%
← FY 2016
All Quarters
Q4 2016 →
